Functional Brain Imaging Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for functional brain imaging systems. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Functional Brain Imaging Systems Market Size (2024E): USD 5.075 Billion
Projected Market Value (2033F): USD 9.021 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 6.6%

Functional Brain Imaging Systems Market - Report Scope:

Functional brain imaging systems play a crucial role in the diagnosis and treatment of various neurological and psychiatric conditions, including Alzheimer's disease, epilepsy, schizophrenia, and brain tumors. These systems utilize advanced imaging techniques such as fMRI, PET, SPECT, and MEG to map brain activity, providing valuable insights into brain function and aiding in the development of targeted therapies. The market for functional brain imaging systems caters to hospitals, research institutions, diagnostic centers, and academic institutions, offering a range of imaging modalities to suit diverse clinical and research needs.

Market Growth Drivers:

The global functional brain imaging systems market is propelled by several key factors, including increasing prevalence of neurological disorders, advancements in imaging technology, and growing demand for non-invasive diagnostic methods. Rising awareness about the benefits of early diagnosis and personalized treatment plans further drive market expansion. Technological innovations, such as the development of high-resolution imaging systems and portable imaging devices, enhance diagnostic accuracy and patient comfort, fostering market growth. Moreover, the expanding application of functional brain imaging in cognitive neuroscience research and the pharmaceutical industry creates new opportunities for market players to leverage advanced imaging solutions.

Market Restraints:

Despite promising growth prospects, the functional brain imaging systems market faces challenges related to high equipment costs, limited reimbursement coverage, and stringent regulatory requirements. The high cost of functional brain imaging systems and the associated operational expenses pose barriers to adoption, particularly in emerging economies with constrained healthcare budgets. Limited reimbursement for imaging procedures and the complex regulatory landscape governing medical imaging devices further impact market growth. Addressing these economic and regulatory challenges requires concerted efforts from industry stakeholders to promote cost-effective solutions and streamline regulatory pathways.

Market Opportunities:

The functional brain imaging systems market presents significant growth opportunities driven by technological advancements, expanding research applications, and increasing healthcare investments. The integration of artificial intelligence and machine learning in imaging systems enhances image analysis and interpretation, improving diagnostic accuracy and efficiency. Furthermore, the growing focus on brain health and the rising incidence of neurodegenerative diseases stimulate demand for advanced imaging technologies. Strategic collaborations, investment in research and development, and the introduction of user-friendly, cost-effective imaging solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic functional brain imaging landscape.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the functional brain imaging systems market globally?
Which imaging modalities and applications are driving adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the functional brain imaging systems market?
Who are the key players contributing to the functional brain imaging systems market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global functional brain imaging systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global functional brain imaging systems market, including GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced imaging solutions, including high-resolution fMRI, PET-CT, and portable MEG systems, catering to diverse clinical and research needs. Collaborations with healthcare providers, research institutions, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving brain imaging landscape.

Key Companies Profiled:

Koninklijke Philips N.V.
General Electric Company
Canon Medical Systems Corporation
EB Neuro S.p.A.
MinFound Medical Systems Co., Ltd
Neurosoft
Medtronic Plc
Nihon Kohden Corporation
Siemens AG
Hitachi Medical Systems
Elekta

Key Segments Covered in Functional Brain Imaging Systems Industry Research

Product:

Functional MR Imaging (fMRI) System
Functional Near Infrared Spectroscopy (fNIRS) System
Magnetoencephalography (MEG) System
Positron Emission Tomography (PET) System
Electroencephalography (EEG) System

Modality:

Stand-Alone Device
Portable Device

End User:

Hospitals
Office Based Clinics
Ambulatory Surgical Centers
Diagnostic Imaging Centers

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Product Code: PMRREP23050

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Key Regulations
4.3. Reimbursement scenario
4.4. Value Chain Analysis
4.5. PESTEL Analysis
4.6. Porter's Analysis
4.7. Key Promotional Strategies, By Key Players

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Medical Imaging Equipment Market Overview
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Rising Incidents of Brain Disorders
- 5.2.2. Introduction of Novel Products
- 5.2.3. Rising Volumes of Surgical Procedure
- 5.2.4. Adoption Rate of Functional Brain Imaging Systems
- 5.2.5. Rising Geriatric Population
- 5.2.6. Increasing Government Spending and Investments
- 5.2.7. Technological Advancements
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Product
- 6.1.2. By Modality
- 6.1.3. By End User
- 6.1.4. By Country
6.2. 2024 Market Scenario

7. Global Functional Brain Imaging Systems Market Demand (in Volume (Units)) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Volume (Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (Units) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Functional Brain Imaging Systems Market - Pricing Analysis

8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
- 8.2.1. Manufacturer Level Pricing
- 8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions

9. Global Functional Brain Imaging Systems Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 9.2.1. Y-o-Y Growth Trend Analysis
- 9.2.2. Absolute $ Opportunity Analysis

10. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Product

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
- 10.3.1. Functional MR Imaging (fMRI) System
- 10.3.2. Functional Near Infrared Spectroscopy (fNIRS) System
- 10.3.3. Magenetoencephalography (MEG) System
- 10.3.4. Positron Emission Tomography (PET) System
- 10.3.5. Electroencephalography (EEG) System
10.4. Market Attractiveness Analysis By Product

11. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By Modality, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Modality, 2024-2033
- 11.3.1. Stand-Alone Device
- 11.3.2. Portable Device
11.4. Market Attractiveness Analysis By Modality

12. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By End User

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
- 12.3.1. Hospitals
- 12.3.2. Office Based Clinics
- 12.3.3. Ambulatory Surgical Centers
- 12.3.4. Diagnostic Imaging Centers
12.4. Market Attractiveness Analysis By End User

13. Global Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033, By Region

13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. East Asia
- 13.3.5. South Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region

14. North America Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. U.S.
  - 14.3.1.2. Canada
- 14.3.2. By Product
- 14.3.3. By Modality
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Modality
- 14.4.4. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
- 14.8.1. U.S. Functional Brain Imaging Systems Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Product
    - 14.8.1.2.2. By Modality
    - 14.8.1.2.3. By End User
- 14.8.2. Canada Functional Brain Imaging Systems Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Product
    - 14.8.2.2.2. By Modality
    - 14.8.2.2.3. By End User

15. Latin America Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. Mexico
  - 15.3.1.2. Brazil
  - 15.3.1.3. Argentina
  - 15.3.1.4. Rest of Latin America
- 15.3.2. By Product
- 15.3.3. By Modality
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Modality
- 15.4.4. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
- 15.8.1. Mexico Functional Brain Imaging Systems Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By Modality
    - 15.8.1.2.3. By End User
- 15.8.2. Brazil Functional Brain Imaging Systems Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By Modality
    - 15.8.2.2.3. By End User
- 15.8.3. Argentina Functional Brain Imaging Systems Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Product
    - 15.8.3.2.2. By Modality
    - 15.8.3.2.3. By End User

16. Europe Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Germany
  - 16.3.1.2. Italy
  - 16.3.1.3. France
  - 16.3.1.4. U.K.
  - 16.3.1.5. Spain
  - 16.3.1.6. BENELUX
  - 16.3.1.7. Russia
  - 16.3.1.8. Rest of Europe
- 16.3.2. By Product
- 16.3.3. By Modality
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Modality
- 16.4.4. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
- 16.8.1. Germany Functional Brain Imaging Systems Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By Modality
    - 16.8.1.2.3. By End User
- 16.8.2. Italy Functional Brain Imaging Systems Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By Modality
    - 16.8.2.2.3. By End User
- 16.8.3. France Functional Brain Imaging Systems Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Product
    - 16.8.3.2.2. By Modality
    - 16.8.3.2.3. By End User
- 16.8.4. U.K. Functional Brain Imaging Systems Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.4.2.1. By Product
    - 16.8.4.2.2. By Modality
    - 16.8.4.2.3. By End User
- 16.8.5. Spain Functional Brain Imaging Systems Market Analysis
  - 16.8.5.1. Introduction
  - 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.5.2.1. By Product
    - 16.8.5.2.2. By Modality
    - 16.8.5.2.3. By End User
- 16.8.6. BENELUX Functional Brain Imaging Systems Market Analysis
  - 16.8.6.1. Introduction
  - 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.6.2.1. By Product
    - 16.8.6.2.2. By Modality
    - 16.8.6.2.3. By End User
- 16.8.7. Russia Functional Brain Imaging Systems Market Analysis
  - 16.8.7.1. Introduction
  - 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.7.2.1. By Product
    - 16.8.7.2.2. By Modality
    - 16.8.7.2.3. By End User

17. East Asia Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
- 17.3.2. By Product
- 17.3.3. By Modality
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Modality
- 17.4.4. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
- 17.8.1. China Functional Brain Imaging Systems Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By Modality
    - 17.8.1.2.3. By End User
- 17.8.2. Japan Functional Brain Imaging Systems Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By Modality
    - 17.8.2.2.3. By End User
- 17.8.3. South Korea Functional Brain Imaging Systems Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.3.2.1. By Product
    - 17.8.3.2.2. By Modality
    - 17.8.3.2.3. By End User

18. South Asia Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. India
  - 18.3.1.2. Indonesia
  - 18.3.1.3. Malaysia
  - 18.3.1.4. Thailand
  - 18.3.1.5. Rest of South Asia
- 18.3.2. By Product
- 18.3.3. By Modality
- 18.3.4. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Modality
- 18.4.4. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players - Intensity Mapping
18.8. Country Level Analysis & Forecast
- 18.8.1. India Functional Brain Imaging Systems Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Product
    - 18.8.1.2.2. By Modality
    - 18.8.1.2.3. By End User
- 18.8.2. Indonesia Functional Brain Imaging Systems Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Product
    - 18.8.2.2.2. By Modality
    - 18.8.2.2.3. By End User
- 18.8.3. Malaysia Functional Brain Imaging Systems Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.3.2.1. By Product
    - 18.8.3.2.2. By Modality
    - 18.8.3.2.3. By End User
- 18.8.4. Thailand Functional Brain Imaging Systems Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.4.2.1. By Product
    - 18.8.4.2.2. By Modality
    - 18.8.4.2.3. By End User

19. Oceania Functional Brain Imaging Systems Market 2019-2023 and Forecast 2024-2033

19.1. Introduction
19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 19.3.1. By Country
  - 19.3.1.1. Australia
  - 19.3.1.2. New Zealand
- 19.3.2. By Product
- 19.3.3. By Modality
- 19.3.4. By End User
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Product
- 19.4.3. By Modality
- 19.4.4. By End User
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Players - Intensity Mapping
19.8. Country Level Analysis & Forecast
- 19.8.1. Australia Functional Brain Imaging Systems Market Analysis
  - 19.8.1.1. Introduction
  - 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.1.2.1. By Product
    - 19.8.1.2.2. By Modality
    - 19.8.1.2.3. By End User
- 19.8.2. New Zealand Functional Brain Imaging Systems Market Analysis
  - 19.8.2.1. Introduction
  - 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 19.8.2.2.1. By Product
    - 19.8.2.2.2. By Modality
    - 19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Functional Brain Imaging Systems Market Analysis 2019-2023 and Forecast 2024-2033

20.1. Introduction
20.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast Analysis By Market Taxonomy, 2024-2033
- 20.3.1. By Country
  - 20.3.1.1. GCC Countries
  - 20.3.1.2. Turkey
  - 20.3.1.3. North Africa
  - 20.3.1.4. South Africa
  - 20.3.1.5. Rest of Middle East and Africa
- 20.3.2. By Product
- 20.3.3. By Modality
- 20.3.4. By End User
20.4. Market Attractiveness Analysis
- 20.4.1. By Country
- 20.4.2. By Product
- 20.4.3. By Modality
- 20.4.4. By End User
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Key Players - Intensity Mapping
20.8. Country Level Analysis & Forecast
- 20.8.1. GCC Countries Functional Brain Imaging Systems Market Analysis
  - 20.8.1.1. Introduction
  - 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.1.2.1. By Product
    - 20.8.1.2.2. By Modality
    - 20.8.1.2.3. By End User
- 20.8.2. Turkey Functional Brain Imaging Systems Market Analysis
  - 20.8.2.1. Introduction
  - 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.2.2.1. By Product
    - 20.8.2.2.2. By Modality
    - 20.8.2.2.3. By End User
- 20.8.3. South Africa Functional Brain Imaging Systems Market Analysis
  - 20.8.3.1. Introduction
  - 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.3.2.1. By Product
    - 20.8.3.2.2. By Modality
    - 20.8.3.2.3. By End User
- 20.8.4. North Africa Functional Brain Imaging Systems Market Analysis
  - 20.8.4.1. Introduction
  - 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 20.8.4.2.1. By Product
    - 20.8.4.2.2. By Modality
    - 20.8.4.2.3. By End User

21. Market Structure Analysis

21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis

22. Competition Analysis

22.1. Competition Dashboard
22.2. Competition Deep Dive
- 22.2.1. Koninklijke Philips N.V.
  - 22.2.1.1. Overview
  - 22.2.1.2. Product Portfolio
  - 22.2.1.3. Sales Footprint
  - 22.2.1.4. Key Financials
  - 22.2.1.5. SWOT Analysis
  - 22.2.1.6. Strategy Overview
    - 22.2.1.6.1. Marketing Strategy
    - 22.2.1.6.2. Product Strategy
    - 22.2.1.6.3. Channel Strategy
- 22.2.2. General Electric Company
  - 22.2.2.1. Overview
  - 22.2.2.2. Product Portfolio
  - 22.2.2.3. Sales Footprint
  - 22.2.2.4. Key Financials
  - 22.2.2.5. SWOT Analysis
  - 22.2.2.6. Strategy Overview
    - 22.2.2.6.1. Marketing Strategy
    - 22.2.2.6.2. Product Strategy
    - 22.2.2.6.3. Channel Strategy
- 22.2.3. Canon Medical Systems Corporation
  - 22.2.3.1. Overview
  - 22.2.3.2. Product Portfolio
  - 22.2.3.3. Sales Footprint
  - 22.2.3.4. Key Financials
  - 22.2.3.5. SWOT Analysis
  - 22.2.3.6. Strategy Overview
    - 22.2.3.6.1. Marketing Strategy
    - 22.2.3.6.2. Product Strategy
    - 22.2.3.6.3. Channel Strategy
- 22.2.4. EB Neuro S.p.A.
  - 22.2.4.1. Overview
  - 22.2.4.2. Product Portfolio
  - 22.2.4.3. Sales Footprint
  - 22.2.4.4. Key Financials
  - 22.2.4.5. SWOT Analysis
  - 22.2.4.6. Strategy Overview
    - 22.2.4.6.1. Marketing Strategy
    - 22.2.4.6.2. Product Strategy
    - 22.2.4.6.3. Channel Strategy
- 22.2.5. MinFound Medical Systems Co., Ltd
  - 22.2.5.1. Overview
  - 22.2.5.2. Product Portfolio
  - 22.2.5.3. Sales Footprint
  - 22.2.5.4. Key Financials
  - 22.2.5.5. SWOT Analysis
  - 22.2.5.6. Strategy Overview
    - 22.2.5.6.1. Marketing Strategy
    - 22.2.5.6.2. Product Strategy
    - 22.2.5.6.3. Channel Strategy
- 22.2.6. Neurosoft
  - 22.2.6.1. Overview
  - 22.2.6.2. Product Portfolio
  - 22.2.6.3. Sales Footprint
  - 22.2.6.4. Key Financials
  - 22.2.6.5. SWOT Analysis
  - 22.2.6.6. Strategy Overview
    - 22.2.6.6.1. Marketing Strategy
    - 22.2.6.6.2. Product Strategy
    - 22.2.6.6.3. Channel Strategy
- 22.2.7. Medtronic Plc
  - 22.2.7.1. Overview
  - 22.2.7.2. Product Portfolio
  - 22.2.7.3. Sales Footprint
  - 22.2.7.4. Key Financials
  - 22.2.7.5. SWOT Analysis
  - 22.2.7.6. Strategy Overview
    - 22.2.7.6.1. Marketing Strategy
    - 22.2.7.6.2. Product Strategy
    - 22.2.7.6.3. Channel Strategy
- 22.2.8. Nihon Kohden Corporation
  - 22.2.8.1. Overview
  - 22.2.8.2. Product Portfolio
  - 22.2.8.3. Sales Footprint
  - 22.2.8.4. Key Financials
  - 22.2.8.5. SWOT Analysis
  - 22.2.8.6. Strategy Overview
    - 22.2.8.6.1. Marketing Strategy
    - 22.2.8.6.2. Product Strategy
    - 22.2.8.6.3. Channel Strategy
- 22.2.9. Hitachi Medical Systems
  - 22.2.9.1. Overview
  - 22.2.9.2. Product Portfolio
  - 22.2.9.3. Sales Footprint
  - 22.2.9.4. Key Financials
  - 22.2.9.5. SWOT Analysis
  - 22.2.9.6. Strategy Overview
    - 22.2.9.6.1. Marketing Strategy
    - 22.2.9.6.2. Product Strategy
    - 22.2.9.6.3. Channel Strategy
- 22.2.10. Elekta
  - 22.2.10.1. Overview
  - 22.2.10.2. Product Portfolio
  - 22.2.10.3. Sales Footprint
  - 22.2.10.4. Key Financials
  - 22.2.10.5. SWOT Analysis
  - 22.2.10.6. Strategy Overview
    - 22.2.10.6.1. Marketing Strategy
    - 22.2.10.6.2. Product Strategy
    - 22.2.10.6.3. Channel Strategy
- 22.2.11. Siemens AG
  - 22.2.11.1. Overview
  - 22.2.11.2. Product Portfolio
  - 22.2.11.3. Sales Footprint
  - 22.2.11.4. Key Financials
  - 22.2.11.5. SWOT Analysis
  - 22.2.11.6. Strategy Overview
    - 22.2.11.6.1. Marketing Strategy
    - 22.2.11.6.2. Product Strategy
    - 22.2.11.6.3. Channel Strategy